BETAAccess all features while we're in beta! Some features may become paid later.Send feedback →

Loading BLTE charts…

Search ticker or company⌘K

BLTE

01Multicharts 02Comparables 03Price target

May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy

BLTE · Belite Bio, Inc. fundamentals · vpside

⌘K

BLTEMarket cap $5.2B/Last filing 20-F · 31 Mar 2026/BLTEMarket cap $5.2B/Last filing 20-F · 31 Mar 2026/BLTEMarket cap $5.2B/Last filing 20-F · 31 Mar 2026/BLTEMarket cap $5.2B/Last filing 20-F · 31 Mar 2026/

Filings synced 13:22 · Prices: prior close 30 Oct

BLTE

Belite Bio, Inc.

Nasdaq · Pharmaceutical preparations (SIC 2834) · FY ends 31 Dec

01Multicharts 02Comparables 03Price target

Add a metric37 metrics

Revenue, quarterly

—

Not reported in this company’s filings

Company filingsvpside.com

Gross margin, trailing twelve months

—

Not reported in this company’s filings

Company filingsvpside.com

Cash and cash equivalents, quarter-end

—

Not reported in this company’s filings

Company filingsvpside.com

Free cash flow, trailing twelve months

—

Not reported in this company’s filings

Company filingsvpside.com

Chart 05 is empty

Chart 06 is empty

Fundamentals: company filings · Q4 = full year − nine months · TTM = last four quarters